Skip to main content

Cancer-targeted imaging and therapy

Cancer is a pivotal medical application of nanotechnology. Nano-scale materials provide unlimited advantages of pinpointed diagnosis by molecular detection of tumor microenvironment and targeted molecular therapy in response to pathological stimuli. Since the key concept of utilizing nanotechnology in cancer diagnosis and therapy was conceived a few decades ago, immense research and development efforts have been invested with relatively little successes. This theme issue will overview the current status and key accomplishment in the field as well as offering perspectives and guides for the next generation nanotechnology in cancer imaging and therapy. 

Guest editor:
Young Jik Kwon, University of California, Irvine, USA,

  1. Cancer has been a serious threat to human health. Among drug delivery carriers, protein nanoparticles are unique because of their mild and environmentally friendly preparation methods. They also inherit desire...

    Authors: Yao Miao, Tao Yang, Shuxu Yang, Mingying Yang and Chuanbin Mao
    Citation: Nano Convergence 2022 9:2
  2. Modern medicine has been waging a war on cancer for nearly a century with no tangible end in sight. Cancer treatments have significantly progressed, but the need to increase specificity and decrease systemic t...

    Authors: Jessica A. Kemp and Young Jik Kwon
    Citation: Nano Convergence 2021 8:34
  3. Hepatocellular carcinoma (HCC) is one of the most malignant tumors in the world, and patients with HCC face a poor prognosis. The conventional therapeutic strategies for HCC have undergone a challenge-riddled ...

    Authors: Tianxiu Dong, Jian Jiang, Hao Zhang, Hongyuan Liu, Xiaomeng Zou, Jiamei Niu, Yingxuan Mao, Mingwei Zhu, Xi Chen, Zizhuo Li, Yaodong Chen, Chunying Shi and Xiuhua Yang
    Citation: Nano Convergence 2021 8:29

Annual Journal Metrics

  • 2022 Citation Impact
    11.7 - 2-year Impact Factor
    9.3 - 5-year Impact Factor
    1.969 - SNIP (Source Normalized Impact per Paper)
    1.891 - SJR (SCImago Journal Rank)

    2023 Speed
    27 days submission to first editorial decision for all manuscripts (Median)
    76 days submission to accept (Median)

    2023 Usage 
    73 Altmetric mentions